| Cancer upregulated gene 2, a novel oncogene, enhances migration and drug resistance of colon cancer cells via STAT1 activation. | colorectal, |
| Report provides evidence that CUG2 induces the EMT in human lung cancer cells via enhancement of TGF-beta signaling and that that TGF-beta signaling is a potential target for CUG2-mediated oncogenesis. | lung, |
| Molecular cloning and functional analysis of a novel oncogene, cancer-upregulated gene 2 (CUG2). | None |
| CUG2, a novel oncogene confers reoviral replication through Ras and p38 signaling pathway. | None |
| Cancer upregulated gene 2, a novel oncogene, confers resistance to oncolytic vesicular stomatitis virus through STAT1-OASL2 signaling. | None |
| The novel CUG2 oncogene promotes cellular transformation and stemness, mediated by nuclear NPM1 protein and TGF-beta signaling. | None |